tirzepatide shortage news october 2025 Mounjaro and Zepbound no longer in National Hispanic Medical Association |

Incretin combination therapy for the treatment of non-alcoholic steatohepatitis

The only instructional material was a one-page card with a QR code labeled how to inject. That is thin guidance for a patient injecting for the first time, which presents a safety concern because the FDA has reported dosing errors with compounded injectable semaglutide, including some adverse events requiring hospitalization

Tirzepatide is a prescription medication available as Mounjaro for diabetes management , and Zepbound for weight loss and obstructive sleep apnea (OSA)

We are thrilled that todays findings showed the superior weight loss of Zepbound, which helped patients achieve 47 percent more relative weight loss compared to Wegovy

The FDA will likely take Wegovy and Ozempic off the shortage list at some point

Once you add bacteriostatic water, the 28-day clock starts immediately